Isoginkgetin antagonizes ALS pathologies in its animal and patient iPSC models via PINK1-Parkin-dependent mitophagy
Ang Li(Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Huanxing Su(University of Macau), Weidong Le(Shanghai University of Medicine and Health Sciences), Jinyi Lin(Jiangsu University), Maoyuan Jiang(University of Macau), Han‐Ming Shen(University of Macau), Sen Huang(Sun Yat-sen University), Feng Yu(University of Macau), Jing Wen(Guangdong Academy of Agricultural Sciences), Guang Lu(National University of Singapore), Evandro Fei Fang(National Institutes of Health), Miaodan Huang(University of Macau), Jiahong Lu(University of Macau), Xiaoli Yao(Second Military Medical University), Yong Liu(Second Affiliated Hospital of Guangzhou Medical University), Peng Li(Kunming Medical University), Lei Yang(University of Oslo), Ke Zhang(Guiyang Medical University), Jiaqi Xin(University of Macau), Shuqin Cao(University of Oslo), Dajiang Qin(Guangzhou Medical University), Lingli Yan(University of Macau), Linping Zhao(Guangzhou Medical University)
Cited by 9
Related Papers
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
|Nature Neuroscience|2019|1.7k
Dual Role of 3-Methyladenine in Modulation of Autophagy via Different Temporal Patterns of Inhibition on Class I and III Phosphoinositide 3-Kinase
|Journal of Biological Chemistry|2010|1.1k
Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms
|Trends in Neurosciences|2017|861
Autophagy in neurodegenerative diseases: pathogenesis and therapy
|Brain Pathology|2017|443
Mitophagy and Neuroprotection
|Trends in Molecular Medicine|2019|443